9-(2-hydroxy-3-nonyl)adenine has been researched along with rp 73401 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Esch, IJ; de Graaf, C; Jansen, C; Kanev, GK; Kooistra, AJ; Leurs, R | 1 |
Favot, L; Holl, V; Keravis, T; Le Bec, A; Lugnier, C | 1 |
2 other study(ies) available for 9-(2-hydroxy-3-nonyl)adenine and rp 73401
Article | Year |
---|---|
PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design.
Topics: Databases, Protein; Dose-Response Relationship, Drug; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship | 2016 |
VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 8-Bromo Cyclic Adenosine Monophosphate; Adenine; Allantois; Animals; Benzamides; Cell Cycle; Cell Division; Cell Movement; Cells, Cultured; Chick Embryo; Chorion; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide Phosphodiesterases, Type 4; Endothelium, Vascular; Enzyme Inhibitors; Humans; Intracellular Membranes; Neovascularization, Physiologic; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridines; Umbilical Veins; Vascular Endothelial Growth Factor A | 2003 |